• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于间充质干细胞的细胞疗法治疗急性/慢性肾脏病的潜力和疗效。

Potential and Therapeutic Efficacy of Cell-based Therapy Using Mesenchymal Stem Cells for Acute/chronic Kidney Disease.

机构信息

Medical Science Research Institute, Soonchunhyang University Seoul Hospital, Seoul 04401, Korea.

Department of Biochemistry, Soonchunhyang University College of Medicine, Cheonan 34538, Korea.

出版信息

Int J Mol Sci. 2019 Apr 1;20(7):1619. doi: 10.3390/ijms20071619.

DOI:10.3390/ijms20071619
PMID:30939749
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6479813/
Abstract

Kidney disease can be either acute kidney injury (AKI) or chronic kidney disease (CKD) and it can lead to the development of functional organ failure. Mesenchymal stem cells (MSCs) are derived from a diverse range of human tissues. They are multipotent and have immunomodulatory effects to assist in the recovery from tissue injury and the inhibition of inflammation. Numerous studies have investigated the feasibility, safety, and efficacy of MSC-based therapies for kidney disease. Although the exact mechanism of MSC-based therapy remains uncertain, their therapeutic value in the treatment of a diverse range of kidney diseases has been studied in clinical trials. The use of MSCs is a promising therapeutic strategy for both acute and chronic kidney disease. The mechanism underlying the effects of MSCs on survival rate after transplantation and functional repair of damaged tissue is still ambiguous. The paracrine effects of MSCs on renal recovery, optimization of the microenvironment for cell survival, and control of inflammatory responses are thought to be related to their interaction with the damaged kidney environment. This review discusses recent experimental and clinical findings related to kidney disease, with a focus on the role of MSCs in kidney disease recovery, differentiation, and microenvironment. The therapeutic efficacy and current applications of MSC-based kidney disease therapies are also discussed.

摘要

肾脏疾病可以是急性肾损伤(AKI)或慢性肾脏病(CKD),它可能导致功能性器官衰竭。间充质干细胞(MSCs)来源于多种人类组织。它们具有多能性和免疫调节作用,有助于从组织损伤中恢复和抑制炎症。许多研究已经探讨了基于 MSC 的疗法治疗肾脏疾病的可行性、安全性和疗效。尽管基于 MSC 的治疗的确切机制尚不确定,但它们在临床试验中治疗各种肾脏疾病的治疗价值已得到研究。使用 MSC 是治疗急性和慢性肾脏病的有前途的治疗策略。MSC 对移植后生存率和损伤组织功能修复的影响的机制仍不清楚。MSC 对肾脏恢复的旁分泌作用、细胞存活的微环境优化和炎症反应的控制被认为与其与受损肾脏环境的相互作用有关。本文讨论了与肾脏疾病相关的最近的实验和临床发现,重点是 MSC 在肾脏疾病恢复、分化和微环境中的作用。还讨论了基于 MSC 的肾脏疾病治疗的治疗效果和当前应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47c8/6479813/45c8475f6ea8/ijms-20-01619-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47c8/6479813/473af290f080/ijms-20-01619-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47c8/6479813/b5e701562ce0/ijms-20-01619-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47c8/6479813/45c8475f6ea8/ijms-20-01619-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47c8/6479813/473af290f080/ijms-20-01619-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47c8/6479813/b5e701562ce0/ijms-20-01619-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47c8/6479813/45c8475f6ea8/ijms-20-01619-g003.jpg

相似文献

1
Potential and Therapeutic Efficacy of Cell-based Therapy Using Mesenchymal Stem Cells for Acute/chronic Kidney Disease.基于间充质干细胞的细胞疗法治疗急性/慢性肾脏病的潜力和疗效。
Int J Mol Sci. 2019 Apr 1;20(7):1619. doi: 10.3390/ijms20071619.
2
Mesenchymal Stem Cells in Kidney Repair.肾脏修复中的间充质干细胞
Methods Mol Biol. 2016;1416:89-107. doi: 10.1007/978-1-4939-3584-0_5.
3
Current understanding of the administration of mesenchymal stem cells in acute kidney injury to chronic kidney disease transition: a review with a focus on preclinical models.当前对间充质干细胞在急性肾损伤向慢性肾脏病转变中的应用的认识:以临床前模型为重点的综述。
Stem Cell Res Ther. 2019 Dec 16;10(1):385. doi: 10.1186/s13287-019-1507-3.
4
Mesenchymal stem cell-derived extracellular vesicles for kidney repair: current status and looming challenges.间质干细胞衍生的细胞外囊泡在肾脏修复中的应用:现状与潜在挑战。
Stem Cell Res Ther. 2017 Dec 4;8(1):273. doi: 10.1186/s13287-017-0727-7.
5
Enhancement of Functionality and Therapeutic Efficacy of Cell-Based Therapy Using Mesenchymal Stem Cells for Cardiovascular Disease.利用间充质干细胞增强细胞疗法在心血管疾病中的功能和治疗效果。
Int J Mol Sci. 2019 Feb 24;20(4):982. doi: 10.3390/ijms20040982.
6
Gene-modified Mesenchymal Stem Cell-based Therapy in Renal Ischemia- Reperfusion Injury.基因修饰间充质干细胞治疗肾缺血再灌注损伤。
Curr Gene Ther. 2017;17(6):453-460. doi: 10.2174/1566523218666180214094253.
7
Mesenchymal Stem Cell-Derived Extracellular Vesicles to the Rescue of Renal Injury.间充质干细胞衍生的细胞外囊泡对肾损伤的修复作用。
Int J Mol Sci. 2021 Jun 20;22(12):6596. doi: 10.3390/ijms22126596.
8
Comparison of the treatment efficacy of umbilical mesenchymal stem cell transplantation via renal subcapsular and parenchymal routes in AKI-CKD mice.肾被膜下和实质内途径移植脐带间充质干细胞治疗 AKI-CKD 小鼠的疗效比较。
Stem Cell Res Ther. 2022 Mar 25;13(1):128. doi: 10.1186/s13287-022-02805-3.
9
Melatonin-stimulated exosomes enhance the regenerative potential of chronic kidney disease-derived mesenchymal stem/stromal cells via cellular prion proteins.褪黑素刺激的外泌体通过细胞朊病毒蛋白增强慢性肾脏病源性间充质干细胞/基质细胞的再生潜能。
J Pineal Res. 2020 Apr;68(3):e12632. doi: 10.1111/jpi.12632. Epub 2020 Feb 17.
10
Mesenchymal stem cell therapy in acute kidney injury (AKI): review and perspectives.急性肾损伤中的间充质干细胞治疗:综述与展望
Rev Assoc Med Bras (1992). 2020 Jan 13;66Suppl 1(Suppl 1):s45-s54. doi: 10.1590/1806-9282.66.S1.45.

引用本文的文献

1
Medical embryology and regenerative medicine: research and applications in clinical practice.医学胚胎学与再生医学:临床实践中的研究与应用
Front Cell Dev Biol. 2025 Aug 26;13:1619036. doi: 10.3389/fcell.2025.1619036. eCollection 2025.
2
Autologous and allogeneic mesenchymal stem cell-based therapies for diabetes mellitus: A systematic review and meta-analysis.基于自体和异体间充质干细胞的糖尿病治疗:系统评价与荟萃分析。
World J Stem Cells. 2025 Jul 26;17(7):108202. doi: 10.4252/wjsc.v17.i7.108202.
3
Selective MicroRNA Packaging Reveals Distinct Core Signatures in Human Mesenchymal-Stromal-Cell-Derived Extracellular Vesicles.

本文引用的文献

1
Kidney disease in the Global Burden of Disease Study 2017.《2017年全球疾病负担研究》中的肾脏疾病
Nat Rev Nephrol. 2019 Apr;15(4):193-194. doi: 10.1038/s41581-019-0120-0.
2
Mesenchymal Stem Cell-Derived Exosomes Ameliorated Diabetic Nephropathy by Autophagy Induction through the mTOR Signaling Pathway.间充质干细胞来源的外泌体通过mTOR信号通路诱导自噬改善糖尿病肾病
Cells. 2018 Nov 22;7(12):226. doi: 10.3390/cells7120226.
3
Melatonin protects chronic kidney disease mesenchymal stem cells against senescence via PrP -dependent enhancement of the mitochondrial function.
选择性微小RNA包装揭示人骨髓间充质基质细胞衍生细胞外囊泡中的独特核心特征。
Int J Mol Sci. 2025 Jul 21;26(14):7010. doi: 10.3390/ijms26147010.
4
Effects of Small Extracellular Vesicles Derived From Mesenchymal Stromal Cells on Acute Kidney Injury: A Rat Ischemia-Reperfusion Model.间充质基质细胞来源的小细胞外囊泡对急性肾损伤的影响:大鼠缺血再灌注模型
Cureus. 2025 May 19;17(5):e84411. doi: 10.7759/cureus.84411. eCollection 2025 May.
5
The effects of Klotho delivering mesenchymal stem cell-derived small extracellular vesicles on acute kidney injury.递送间充质干细胞来源的小细胞外囊泡的Klotho对急性肾损伤的影响。
J Nanobiotechnology. 2025 Jun 7;23(1):427. doi: 10.1186/s12951-025-03499-4.
6
Extracellular Vesicles in Acute Kidney Injury: Mechanisms, Biomarkers, and Therapeutic Potential.急性肾损伤中的细胞外囊泡:作用机制、生物标志物及治疗潜力
Int J Nanomedicine. 2025 May 17;20:6271-6288. doi: 10.2147/IJN.S519345. eCollection 2025.
7
Noninvasive DWI tracking of hiPSCs differentiation into RTECs in AKI recovery via the KSP promoter-mediated AQP1 strategy.通过KSP启动子介导的AQP1策略对急性肾损伤恢复过程中hiPSC向RTEC分化进行无创性扩散加权成像追踪
Theranostics. 2025 Apr 9;15(11):5106-5120. doi: 10.7150/thno.109826. eCollection 2025.
8
The Role of Viral Infections in Acute Kidney Injury and Mesenchymal Stem Cell-Based Therapy.病毒感染在急性肾损伤及基于间充质干细胞的治疗中的作用
Stem Cell Rev Rep. 2025 Apr 8. doi: 10.1007/s12015-025-10873-0.
9
Emerging role of mesenchymal stem cell-derived exosomes in the repair of acute kidney injury.间充质干细胞衍生外泌体在急性肾损伤修复中的新兴作用。
World J Stem Cells. 2025 Mar 26;17(3):103360. doi: 10.4252/wjsc.v17.i3.103360.
10
Exosomes of human adipose stem cells mitigate irradiation injury to salivary glands by inhibiting epithelial-mesenchymal transition through miR-199a-3p targeting Twist1 and regulating TGFβ1/Smad3 pathway.人脂肪干细胞外泌体通过miR-199a-3p靶向Twist1抑制上皮-间质转化并调节TGFβ1/Smad3信号通路减轻唾液腺辐射损伤。
Theranostics. 2025 Jan 2;15(5):1622-1641. doi: 10.7150/thno.102346. eCollection 2025.
褪黑素通过 PrP 依赖性增强线粒体功能来保护慢性肾病间充质干细胞免于衰老。
J Pineal Res. 2019 Jan;66(1):e12535. doi: 10.1111/jpi.12535. Epub 2018 Nov 18.
4
Pioglitazone Protects Mesenchymal Stem Cells against -Cresol-Induced Mitochondrial Dysfunction via Up-Regulation of PINK-1.吡格列酮通过上调 PINK-1 保护间充质干细胞免受 - 甲酚诱导的线粒体功能障碍。
Int J Mol Sci. 2018 Sep 24;19(10):2898. doi: 10.3390/ijms19102898.
5
The use of hydrogels for cell-based treatment of chronic kidney disease.水凝胶在基于细胞的慢性肾病治疗中的应用。
Clin Sci (Lond). 2018 Sep 16;132(17):1977-1994. doi: 10.1042/CS20180434. Print 2018 Sep 14.
6
Mesenchymal Stem Cell-Derived Extracellular Vesicles Improve the Renal Microvasculature in Metabolic Renovascular Disease in Swine.间质干细胞衍生的细胞外囊泡改善猪代谢性血管疾病的肾脏微血管。
Cell Transplant. 2018 Jul;27(7):1080-1095. doi: 10.1177/0963689718780942. Epub 2018 Jun 28.
7
Fucoidan Rescues p-Cresol-Induced Cellular Senescence in Mesenchymal Stem Cells via FAK-Akt-TWIST Axis.褐藻糖胶通过 FAK-Akt-TWIST 轴拯救间充质干细胞中 p- Cresol 诱导的细胞衰老。
Mar Drugs. 2018 Apr 6;16(4):121. doi: 10.3390/md16040121.
8
US Renal Data System 2017 Annual Data Report: Epidemiology of Kidney Disease in the United States.美国肾脏数据系统2017年年报:美国肾脏疾病流行病学
Am J Kidney Dis. 2018 Mar;71(3 Suppl 1):A7. doi: 10.1053/j.ajkd.2018.01.002.
9
Stem cell extracellular vesicles and kidney injury.干细胞外泌体与肾损伤
Stem Cell Investig. 2017 Nov 16;4:90. doi: 10.21037/sci.2017.11.02. eCollection 2017.
10
Mesenchymal stem cell-derived extracellular vesicles for kidney repair: current status and looming challenges.间质干细胞衍生的细胞外囊泡在肾脏修复中的应用:现状与潜在挑战。
Stem Cell Res Ther. 2017 Dec 4;8(1):273. doi: 10.1186/s13287-017-0727-7.